(Q48436320)

English

GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study

scientific article published in December 2014

GBA ‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Parkinson's disease

1 reference

based on heuristic

inferred from title

Claudia Schulte

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

7

object named as

Thomas Gasser

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

8

object named as

Daniela Berg

2 references

Europe PubMed Central

PubMed publication ID

11 February 2018

ORCID Public Data File 2021

Walter Maetzler

6

object named as

Walter Maetzler

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

author name string

Kathrin Brockmann

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Karin Srulijes

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Sylvia Pflederer

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Ann-Kathrin Hauser

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

language of work or name

0 references

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

30

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

407-411

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

GBA-associated PD presents with nonmotor characteristics

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

What predicts mortality in Parkinson disease?: a prospective population-based long-term study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

1 reference

https://api.crossref.org/works/10.1002%2FMDS.26071

21 January 2018

Identifiers

10.1002/MDS.26071

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25448271

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48436320&oldid=2198837442"